MTOR and neoplasm: Because mTOR inhibitors have been utilized for cancer therapy, and only modest or unremarkable success has been achieved in some clinical trials [27], [28], it is urgent to investigate the long-term effects of transient mTOR treatment on tumor re-emergence and malignant outcome.